Table 2.

Treatment results

Results	LD	SD
Intention-to-treat
No. of patients	30	27
SVR	19 (63%)	21 (78%)
Relapse/Breakthrough	7 (23%)	2 (7%)
Non-response	3 (10%)	1 (4%)
Treatment stopped for adverse event	0 (0%)	3 (11%)
Lost to follow-up	1 (3%)	0 (0%)
Per protocola
No. of patients	28	23
SVR	19 (68%)	20 (87%)
Relapse/Breakthrough	7 (25%)	2 (9%)
Non-response	2 (7%)	1 (4%)

^aExcluded from analysis:

LD – 1 patient needed peginterferon dose reduction for neutropenia, 1 patient lost to follow-up

SD – 1 patient needed peginterferon dose reduction for neutropenia, 3 patients withdrawn from treatment for serious adverse events